Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intrexon Corp (NYSE:XON)

17.88
Delayed Data
As of Oct 20
 -0.34 / -1.87%
Today’s Change
17.04
Today|||52-Week Range
32.58
-25.71%
Year-to-Date
No recent news for Intrexon Corp.

Today’s Trading

Previous close18.22
Today’s open18.23
Day’s range17.75 - 18.34
Volume1,592,644
Average volume (3 months)874,725
Market cap$2.2B
Dividend yield--
Data as of 4:04pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-107.89%
Earnings growth (this year)+41.14%
Earnings growth (next 5 years)-78.25%
Revenue growth (last year)+9.98%
P/E ratioNM
Price/Sales15.02
Price/Book3.86

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...+0.72+1.12%
HALOHalozyme Therapeutic...+0.05+0.28%
AVXSAveXis Inc-0.46-0.46%
ONCESpark Therapeutics I...+1.08+1.34%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 15, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$190.9M
Annual profit (last year)-$186.6M
Net profit margin-97.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Randal J. Kirk
Chief Operating Officer
Andrew J. Last
Corporate headquarters
Germantown, Maryland

Forecasts